BioControl
BioControl develops advanced diagnostic solutions for infectious diseases and cancer.
About
BioControl is a biotechnology company focused on developing innovative diagnostic tools for critical healthcare needs. Their technology aims to provide rapid, accurate, and cost-effective detection of infectious diseases and cancer markers, enabling earlier diagnosis and improved patient outcomes. They serve clinical laboratories and healthcare providers.
Also in this space
Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.
Shares Healthcare, Diagnostics
Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.
Shares Healthcare, Diagnostics
Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.
Shares Healthcare, Diagnostics
Remote-controlled micro-robots for precise treatment of central nervous system disorders.
Shares Healthcare, Diagnostics
MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.
Shares Healthcare, Diagnostics
Pentaomix develops a breakthrough biopsy imaging modality for unprecedented accuracy in pathology analysis.
Shares Healthcare, Diagnostics
Key facts
- Website
- biocontrol.com
- Headquarters
- Cucamonga, United States
- Founded
- 1999
- Total funding
- $76M (Strategic)
- Business model
- B2B
Funding rounds
BioControl scores 22. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is BioControl trustworthy and reputable?
StartupHub's Data Trust & Reputation score for BioControl is 58 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has BioControl raised?
BioControl has raised a total of $76M in funding. The most recent round on record is Strategic.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for BioControl

